SmeNSEHealthcareUPCOMING

Bio Medica Laboratories IPO

TBA · Issue Size

IPO Overview

StatusUpcoming
Price BandTBA
Issue Size
Lot Size
Min Investment
Face Value₹10
Issue Structure
Fresh Issue
Offer for Sale₹3,76,800 Cr
Total Size

Business Model

Competitive Advantages
  • Experienced promoters, management and employees:
  • We have an experienced management team with an established process led by our promoters, Mr. Pradeep
  • Mehta and Mr. Mukesh Mehta, who have significant industry experience of more than 37 years in the
  • Our Company holds Good Laboratory Practice (GLP) and Good Manufacturing Practices (GMP) Certificate

IPO Timeline

Open Date21 May 2026
Close Date25 May 2026
Allotment26 May 2026
Refund27 May 2026
Credit to Demat27 May 2026
Listing Date28 May 2026

Objects of the Issue

The Offer comprises of Fresh Issue up to 33,95,000 Equity Shares of face value Rs. 10/- each, aggregating up to Rs. Lakhs by the company and an Offer for Sale of up to 3,77,000 Equity Shares of face value of Rs.

Strengths & Weaknesses

Strengths

  • Experienced promoters, management and employees:
  • We have an experienced management team with an established process led by our promoters, Mr. Pradeep
  • Mehta and Mr. Mukesh Mehta, who have significant industry experience of more than 37 years in the
  • Our Company holds Good Laboratory Practice (GLP) and Good Manufacturing Practices (GMP) Certificate

Management & Promoters

M
Madhya Pradesh.Non-Executive Independent Director
P
Pradeep MehtaManaging Director
I
Indian PublicNon-Executive Director
M
Mukesh MehtaWhole-Time Director
C
Companies- NilNon-Executive Director
S
Surabhi MahajanNon-Executive Director
D
Divya KhandelwalIndependent Director
P
Professionals LLPIndependent Director
S
Sumeet BansalIndependent Director
N
NIL Indian PrivateCompany Secretary
N
Name Pradeep MehtaManaging Director
P
Perquisite N.A.Whole-Time Director

Shareholding Pattern

Pre-IPO
Category%
Promoters26%
Employees27%

Peer Comparison

CompanyP/EEPS
Bio Medica Laboratories IPO
Telephone: -33.0x
CIN: UWBPLC
Telephone: +---91.0x
CIN: UDLPTC

Pre-IPO Financials

PeriodRevenue (Cr)PAT (Cr)Net Worth (Cr)Total Assets (Cr)
November 2025₹0.31 Cr₹0.31 Cr₹17.57 Cr
March 2025₹20.23 Cr₹20.23 Cr₹0.56 Cr
March 2024₹0.01 Cr₹0.01 Cr₹3.86 Cr

About

Bio Medica Laboratories is one of the leading manufacturers of parenteral medicines (injectable products) in India. The firm has been involved in developing a wide range of parenteral medicines targeting both human and animal needs. They manufacture generic medicines in the form of Liquid injections and dry powder injections, which come in various forms of packaging like ampoules and vials. The company also claims to offer high-quality and safe products, followed by Good Manufacturing Practices

ExchangeNSE
Issue Typesme
SectorHealthcare
Face Value10 per share

Documents

rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.